IMPPC Fundación Institut de Medicina Predictiva i Personalitzada del CàncerThe purpose of this introduction is to explain the context the project and the reasons for its creation in this area of Spain and its objectives as a center for pioneering research. For those with further questions about our project, please contact us on info@imppc.org.
The IMPPC is one of the latest of the biomedical centers to be established in the context of the Catalan BioRegion and its collaboration with other research and health centers in the area are fundamental to its research strategy. One of these partners is the Institute for Health Science Research Germans Trias i Pujol (FIICSGTiP), the management body for an association of research centers presided over by the Minister of Health. The new IMPPC building is adjacent to the FIICSGTiP. The centers in the complex comprise:
• Germans Trias i Pujol University Hospital HUGTIP
• Universidad Autónoma de Barcelona (Autonomous University of Barcelona)(UAB)
• Catalan Institute of Oncology (ICO)
• IDI
• CTBT (Centre de Transfusió i Banc de Teixits)
• irsiCaixa Foundation
• Guttman Institute
The Germans Trias i Pujol University
Hospital (HUGTiP) and the Institute for Health Science Research Germans Trias i
Pujol (FIICSGTiP) are located in Badalona, 20 minutes from the center of
Barcelona. The City Council of Badalona
has generously offered a building in the same complex as the FIISGTiP. The site
offers possibilities not available in the highly built up city of Barcelona and
the IMPPC will be in a prime position next to the hospital and Institute for
Health Science Research.
The scientific director of the institute, Prof. Ricard Pujol I Borrell, Professor in Immunology at the Universitat Autónoma de Barcelona (Autonomous University of Barcelona) has already identified a strategic objective of setting up an institute of Molecular Medicine that already fits closely with this project.